The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 – Spleen and Thymus
Acta Cytologica · 2025
DOI: 10.1159/000548853 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Cytologica, 2025. Verfasst von Immacolata Cozzolino und 19 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, University Hospital A.O.U. Luigi Vanvitelli, Naples, Italy. Hauptthemen laut MEDLINE: Cytodiagnosis, Pathology, Clinical, Spleen, Thymus Gland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Background: The International Academy of Cytology in collaboration with the International Agency for Research on Cancer has developed a standardized World Health Organization Reporting System (WHO System) for the cytopathology of the lymph nodes, spleen, and thymus. Fine-needle aspiration biopsy (FNAB) of the spleen and thymus, performed under ultrasound or computed tomography guidance, constitutes a minimally invasive, well-tolerated, and cost-effective diagnostic technique. Despite a limited number of published studies on the diagnostic accuracy of FNAB in these organs, it remains a valuable tool particularly when combined with rapid on-site evaluation and ancillary techniques, such as immunophenotypic analysis by flow cytometry or immunocytochemistry and molecular testing. Summary: The WHO System categorizes thymic and splenic cytopathology into five diagnostic categories: “Inadequate/Insufficient/Nondiagnostic,” “Benign,” “Atypical,” “Suspicious for malignancy,” and “Malignant.” This standardized approach aims to enhance diagnostic accuracy, provide risk assessment, and facilitate clinical decision-making. However, applicability of FNAB in the thymus and spleen is still debated, particularly concerning sample adequacy, diagnostic accuracy, and potential complications such as hemorrhage, especially for splenic FNAB. Thymic FNAB is primarily used for diagnosing thymic hyperplasia, thymoma, thymic carcinomas, and lymphomas. However, distinguishing these entities and their subtypes is challenging. Splenic FNAB is valuable in evaluating splenomegaly, infections, lymphomas, and other neoplasms, particularly in staging and monitoring disease progression. While using FNAB to evaluate these organs is not yet a widely adopted standard practice, its role in minimizing unnecessary surgical interventions and guiding therapeutic strategies is being increasingly recognized. Key Messages: The WHO System for the thymus and spleen seeks to establish a harmonized, evidence-based framework for cytopathological diagnosis, incorporating key diagnostic criteria, malignancy risk assessment, and standardized reporting protocols. Future research is needed to refine and develop diagnostic role of FNAB, enhance its integration with advanced molecular techniques, and optimize its use in personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pathology Unit, University Hospital A.O.U. Luigi Vanvitelli, Naples, Italy.
- Specialist Integrated Hematological Malignancy Diagnostic Service, Department of Cellular Pathology, Barts Health National Health Service Trust, London, UK.
- Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
- Department of Clinical Sciences, Division of Pathology, Lund University, Lund, Sweden.
- Department of Pathology, Microbiology and Forensic Medicine, the University of Jordan, Amman, Jordan.
- Serviço de Anatomia Patológica, Hospital S João-Porto, Porto, Portugal.
Förderung
- World Health Organization
Zitieren
APA
Cozzolino, I., Calaminici, M., Ronchi, A., Ehinger, M., Al-Abbadi, M. A., Barroca, H., Bode-Lesniewska, B., Chhieng, D. F., Katz, R. L., Lin, O., Medeiros, L. J., Pitman, M. B., Rajwanshi, A., Schmitt, F. C., Vielh, P., Zeppa, P., Cree, I. A., Sewell, W. A., Rekhi, B., & Field, A. S. (2025). The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 – Spleen and Thymus. Acta Cytologica. https://doi.org/10.1159/000548853
Vancouver
Cozzolino I, Calaminici M, Ronchi A, Ehinger M, Al-Abbadi MA, Barroca H, et al. The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 – Spleen and Thymus. Acta Cytologica. 2025. doi:10.1159/000548853
BibTeX
@article{Cozzolino2025,
author = {Cozzolino, Immacolata and Calaminici, Mariarita and Ronchi, Andrea and Ehinger, Mats and Al-Abbadi, Mousa A and Barroca, Helena and Bode-Lesniewska, Beata and Chhieng, David F and Katz, Ruth L and Lin, Oscar and Medeiros, L Jeffrey and Pitman, Martha Bishop and Rajwanshi, Arvind and Schmitt, Fernando C and Vielh, Philippe and Zeppa, Pio and Cree, Ian A and Sewell, William A and Rekhi, Bharat and Field, Andrew S},
title = {The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 – Spleen and Thymus},
journal = {Acta Cytologica},
year = {2025},
doi = {10.1159/000548853}
}
EUVIMED